RBC Capital Starts Alpine Immune Sciences (ALPN) at Outperform, "Povetacicept could be competitively positioned"
Go back to RBC Capital Starts Alpine Immune Sciences (ALPN) at Outperform, "Povetacicept could be competitively positioned"| Alpine Management Systems, Inc. (NASDAQ: ALPN) | Delayed: 64.97 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $64.97 | 52 Week High | $0.00 | |||
| Open | $43.88 | 52 Week Low | $2156.81 | |||
| Day High | $64.97 | P/E | N/A | |||
| Day Low | $64.97 | EPS | $0.00 | |||
| Volume | 6,065 | |||||
